Anti-tumor activity of synthetic peptide fragments of the human interferon-α2

Hybridoma

Volumn 16, Issue 1, 1997, Pages 69-75

  Danilkovitch, A ^a,c   Freze, K ^a   Romashkova, J ^a   Makarov, E ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; MEMBRANE RECEPTOR; RECOMBINANT ALPHA2C INTERFERON; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; BINDING COMPETITION; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CHROMOSOME 21; CONFERENCE PAPER; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYBRID CELL; LYMPHATIC SYSTEM TUMOR; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR CELL LINE;

EID: 0030892552     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1997.16.69     Document Type: Conference Paper

References (19)

1. De Mayer and De Mayer-Guignard: Interferons and Other regulatory Cytokines. John Wiley and Sons, Inc., New York, 1988.
2. Pestka, S, Langer, JA, Zoon, KC, and Samuel, CE: Interferons and their actions, Annu Rev Biochem 1987;56:727-777.
3. Balkwill FR, and Burke F: The cytokine network. Immunol Today 1989;10:299-304.
4. Streuli M, Hall A, Bol W, Stewart WE, Nagata S, and Weissmann C: Target cell specificity of two species of human interferon alpha produced in E. coli and of hybrid molecules derived from them. Proc Natl Acad Sci USA 1981;78:2848-2852.
5. Fish EN, Banerjee K, and Stebbing N: The role of three domains in the biological activity of human interferon-alpha. J Interferon Res 1989;9:97-114.
6. Cebrian M, Yague E, de Landazuri MO, Rodiguez-Moya M, Fresno M, Pezzi N, Uamazares S, and Sanchez-Madrid F: Different functional sites on r IFN-α2 and their relation to the cellular receptor binding site. J Immunol 1987;138:484-490.
7. Ortaldo JR, Mason A, Rehberg E, Mashera J, Kelder B, Pestka S, and Herberman RB: Effects of recombinant and hybrid recombinant human leukocyte interferons on cytotoxic activity of natural killer cells. J Biol Chem 1983;258:15011-15015.
8. Ortaldo JR, Herberman RB, Harrey C, Osheroff P, Pan Y-CE, Kelder B, and Pestka S: A species of human α Interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci 1984;81:4926-4929.
9. Weber H, Valenzuela D, Lujber G, Gubler M, and Weissmann C: Single amino acid changes that render human interferon alpha 2 biological active on mouse cells. EMBO J 1987;6:591-598.
10. Cheetham BF, McInnes B, Mantamadiotis T, Murray PJ, Aalin P, Bourke P, Linnane AW, and Tymms MJ: Structure-function studies of interferon alpha: Amino acid substitutions at the conserved residue tyrosine 123 in human interferon alpha 1. Antiviral Res 1991;15:27-40.
11. Uze G, Lutfalla G, and Gresser I: Genetic transfer of a functional human interferon a receptor into mouse cells: Cloning and expression of its cDNA. Cell 1990;60:225-234.
12. Novick D, Cohen B, and Rubinstein, M: The human interferon α/β receptor: characterization and molecular cloning. Cell 1994;77: 391-400.
13. Domanski P, Witte M, Kellum M, Rubinstein M, Hackelt R, Pitha P, and Colamonici O: Cloning and expression of a long form of the β subunit of the interferon αβ receptor that is required for signalling. J Biol Chem 1995;270:21606-21611.
14. Lutfalla G, Holland SJ, Cinato E, Monneron D, Reboul J, Rogers NC, Smith JM, Stark GR, Gardiner K, Mogensen KE, Kerr IM, and Uze G: Mutant U5A cells are complemented by an interferonαβ receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J 1995;14: 5100-5108.
15. Danilkovitch AV, Freze KV, Shevalier AF, Samukov VV, Kirkin AF, Gusev MV: Synthetic peptide with antiproliferative activity, a short C-terminal fragment of human interferon α-2 molecule. Immunol Lett 1992;31:15-20.
16. Danilkovitch AV, Kharitonenkov AI, Freze KV, Shevalier AF, Kolosova OV, Bulargina TV, Kirkin AF, Gusev MV: Interaction of synthetic peptide of the interferon α-2 Cterminal part with human blood leukocytes. I. Binding to peripheral blood mononuclear cells. FEBS Lett. 1991;295:70-72.
17. Danilkovitch AV, Freze KV, Targoni OS, Karulin AY, Shevalier AF, Gusev MV, and Sukhikh GT: Inhibition of in vitro mitogen-stimulated human lymphocyte's proliferation by synthetic peptides-fragments of interferon α2. Bull Exp Biol Med (Russian) 1994;117:72-75.
18. Shevalier A, Samukov VV, Ofitserov VI, Kalashnikov V, Mizenko GA, and Kolokoltsov AA: Immunochemical and biological properties of synthetic peptide fragments from the amino acid sequence 124-144 of the human leukocyte interferon alpha 2. Bioorg Khim USSR 1990;16:916-920.
19. Callard R, and Gearing A: The Cylokine Facts Book. Academic Press, London, 1994.